AKT1 and metabolic disease: The insulin receptor maintains energy homeostasis by stimulating various downstream pathways including the phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB or Akt) pathway [117], and thus its aberration is observed in metabolic diseases [117,142,143,144,145,146,147,148,149,150].